Overview
Jack Gleeson is a Hematologist Oncology provider practicing medicine in New York, New York.
His clinical expertise encompasses HER-2 Positive Breast Cancer, Glioma, Glioblastoma, and Astrocytoma.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
New York Queens Medicine And Surgery, P.C.
Giuseppe Giaccone is a Hematologist Oncology specialist and an Oncologist practicing medicine in Flushing, New York. Dr. Giaccone is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Thymic Epithelial Tumor, Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics.
Memorial Sloan Kettering Cancer Center
Mark Geyer is a Hematologist Oncology provider practicing medicine in New York, New York. Dr. Geyer is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Geyer is board certified in American Board Of Internal Medicine and Hematology.
Frequently Asked Questions about Dr. Jack P. Gleeson
How do I make an appointment with Dr. Jack P. Gleeson?
You can book an appointment with Dr. Jack P. Gleeson by calling their office at 212-639-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jack P. Gleeson a top-rated expert for HER-2 Positive Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jack P. Gleeson is classified as an Experienced expert for HER-2 Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jack P. Gleeson specialize in?
While Dr. Jack P. Gleeson is a Hematology Oncology, they have specific expertise in HER-2 Positive Breast Cancer, Glioma, and Glioblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Jack P. Gleeson participate in research or clinical trials?
Yes. Dr. Jack P. Gleeson has published 16 articles and abstracts on conditions like HER-2 Positive Breast Cancer. You can view a list of Dr. Jack P. Gleeson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaDr. Gleeson isExperienced. Learn about Astrocytoma.
- Breast CancerDr. Gleeson isExperienced. Learn about Breast Cancer.
- GlioblastomaDr. Gleeson isExperienced. Learn about Glioblastoma.
- GliomaDr. Gleeson isExperienced. Learn about Glioma.
- HER-2 Positive Breast CancerDr. Gleeson isExperienced. Learn about HER-2 Positive Breast Cancer.
- Renal Cell Carcinoma (RCC)Dr. Gleeson isExperienced. Learn about Renal Cell Carcinoma (RCC).
